Fernand Labrie

Participation at SYMPOSIA

Page 2 of 11, showing 50 records out of 506 total, starting on record 51, ending on 100

Year(s) Title
1996 25th Annual Meeting of the Canadian Association on Gerontology, "What is the Impact of Health Research on Geronto-Geriatric Research?", Québec City (October 1996)
1985 27th Meeting of the American Cancer Society for Science Writers, "New Combination Therapy for Prostate Cancer: a Three-Year Experience", San Diego (April 1985)
1980 28th International Congress of Physiological Sciences, "Effects of Endogenous Opioid Peptides on the Neuroendocrine System", Budapest (July 1980)
1985 2nd Annual Meeting of The Québec Geriatric Society , "Comparison of the Combined Treatment with Flutamide in Association with Castration (LHRH Agonist or Orchiectomy) and Orchiectomy Alone in Advanced
1994 2nd Euro-American Conference on Urological Diseases, BPH and Prostate Cancer, “Maximal Androgen Deprivation in Metastatic Prostate Cancer”, Athens (August 1994)
1994 2nd Euro-American Conference on Urological Diseases, BPH and Prostate Cancer, “Strategy for Detection of Early and Curable Prostate Cancer”, Athens (August 1994)
1976 2nd European Colloquium on Hypothalamic Hormones, Tubingen (July 1976)
1974 2nd International Conference on Cyclic AMP, Vancouver (July 1974)
1971 2nd International Congress of Neuropsychoendocrinology, Budapest (1971)
1983 2nd International Congress on Hormones and Cancer, "Complete Androgen Withdrawal with an LHRH Agonist and an Antiandrogen in Prostatic Cancer", Monte Carlo (September 1983)
1977 2nd International Congress on Human Reproduction, "Marked Inhibition of Ovarian and Testicular LH/hCG, FSH and PRL Receptor Levels Accompanying the Antifertility Effects of LHRH Agonists", Tel Aviv (O
1999 2nd International Consultation on Prostate Cancer, World Health Organization, International Union Against Cancer, "Management of Newly Diagnosed Metastatic Prostate Cancer", Paris (June 1999)
1984 2nd International Forum on Andrology, "Dramatic Response to Complete Androgen Blockade in Advanced Prostate Cancer", Paris (June 1984)
1990 2nd International Symposium on GnRH Analogues in Cancer and Human Reproduction, "Geneva (November 1990)
1990 2nd International Symposium on Hormonal Manipulation of Cancer, Peptides, Growth Factors and New (Anti)Steroidal Agents, "Combination Therapy with the LHRH Agonist [D-Trp6,des-Gly-NH210] LHRH Ethylami
1990 2nd International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment, "Down Staging of Advanced Prostatic Lesions with Hormones", Paris (June 1990)
1996 2nd International Symposium on Urology, Nephrology and Transplantation of SIUT, "Recent Advances in the Treatment of Prostate Cancer and Role of Combination Therapy", Karachi, Pakistan (March 1996)
1988 31st Annual Meeting, Canadian Federation of Biological Societies, Symposium on Role of Adrenal Steroids as Precursors of Androgens and Estrogens in Peripheral Tissues, "Role of Steroids of Adrenal Ori
1987 32nd World Congress of Surgery, Symposium of the Société internationale d'urologie on Prostatic Cancer: "Flutamide, Orchiectomy and LHRH Agonists in the Treatment of Patients with Prostatic Cancer", S
1992 34th Congress of La Fédération des gynécologues et obstétriciens de langue française, "La biologie moléculaire en clinique: aspects historiques et justification", Québec City (June 1992)
1996 3e Réunion Atlantestis (chercheurs de la façade atlantique): "Les enzymes de la stéroidogénèse dans le testicule: de la biologie moléculaire à la clinique", Caën (May 1996)
1983 3rd Congress of the European Society of Oncology and Endocrinology, "LHRH Agonists and Antiandrogens in Prostatic Cancer", Rome (November 1983)
2001 3rd Croatian Congress on Menopause and Gynecological Endocrinology, “EM-652 (SCH-57068), an Ideal 4th-Generation SERM for Protection of Women’s Health ”, Dubrovnik (August 2001)
2001 3rd Croatian Congress on Menopause and Gynecological Endocrinology, “Role of Androgens in Women and Potential Use of DHEA as Hormonal Replacement Therapy”, Dubrovnik (August 2001)
1987 3rd International Congress on Hormones and Cancer, "Screening of Lipoidal Steroid Formation in the ZR-75-1 Human Breast Cancer Cell Line", Hamburg (September 1987)
1985 3rd International Forum of Andrology, "Importance of the Uptake and Metabolism of Androgen Precursors in Target Tissues", Paris (June 1985)
1985 3rd International Forum of Andrology, "Three-Year Experience with the Combination Therapy Using Flutamide and an LHRH Agonist in Prostate Cancer", Paris (June 1985)
1981 3rd International Meeting on Human Prolactin, "Control of Pituitary Dopamine Receptor Activity", Athens (October 1981)
2004 3rd International Symposium, "The Science and Technology of Skin Engineering" - "Hormonal Equipment in Skin In Vitro", “The skin as an important site of local formation and action of sex steroids”, La
2001 3rd Macedonian Symposium on Urology, “Status of Androgen Blockade in Prostate Cancer in 2001: Impact on Survival”, Thessaloniki (November 2001)
1995 3rd Midwest and International Symposium on Prostate Cancer, Symposium on The Role of TRUS in the Diagnosis and Treatment of Prostate Cancer, “The Canadian Experience - a Randomized Study With and With
1995 3rd Midwest International Symposium on Prostate Cancer, Symposium on The Role of TRUS in the Diagnosis, Staging and Treatment of Prostate Cancer, “The Science Behind Antiandrogen Combination Therapy”
1986 3rd National Conference of Oncological Forum: "The use of LHRH Analogs and Pure Antiandrogens in the Treatment of Metastatic Prostatic Cancer", Tromso, Norway (October 1986)
1983 3rd Symposium on Catecholamines and Other neurotransmitters in Stress, Czechoslovakia (June 1983)
2000 3rd Teupitz Colloquium on Basic Research in Endocrine Dermatology, “Endocrine Dermatology” “Intracrinology in the Skin”, Berlin (September 2000)
1981 3rd World Congress of Human Reproduction, Berlin (March 1981)
1998 41st Annual Meeting of the Philippine Urological Association, "New Aspects of Hormonal Treatment of prostate Cancer", Manila (December 1998)
1981 43e Congrès français de médecine, "Récepteurs des hormones hypothalamiques", Montpellier (September 1981)
1991 48e Congrès français de médecine (France) et 63e Congrès-exposition de l'Association des médecins de langue française du Canada, "Nouvelles stratégies thérapeutiques - Perspectives dans le diagnostic
2004 4e World Conférence of Science Journalists (WCS) Genomics of Common diseases/Génomique et maladies, « Genome of Hormone-Sensitive Diseases », Montréal (Octobre 2004)
1987 4th European Conference on Clinical Oncology and Cancer Nursing (ECCO 4), Symposium on Advances in Prostate Cancer Treatment, "Combination Therapy with Flutamide", Madrid, Spain (November 1987)
1987 4th International ARC/NIH Symposium Cancers in the Developed World, "Role of Adrenal Steroids in Prostate and Breast Cancer" Washington (December 1987)
1979 4th International Symposium of the Journal of Steroid Biochemistry, "Sex Steroids act at the Pituitary and Hypothalamic Levels to Modulate Prolactin Secretion", Paris (May 1979)
1996 4th International Symposium on GnRH Analogues in Cancer and Human Reproduction, "Combination of Screening and Combination Endocrine Therapy Presurgery and Preradiotherapy in Prostate Cancer", Geneva (
1989 4th International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostatic Cancer, "Optimal Use of 1989 Endocrine Therapy of Prostate Cancer", Chicago (September 1989)
2003 53rd Annual Meeting of the Central Division of the Japan Urological Association, “Recent Progress in Hormonal Treatment of Prostate Cancer”, Kanazawa (November 2003)
1986 58e Congrès exposition international de l'Association des médecins de langue française du Canada, "La LHRH et ses analogues, une nouvelle époque dans le domaine de la reproduction", Montreal (Septembe
1978 5th Annual Workshop on the Testis, "Inhibitory Effects of LHRH and its Agonists on Testicular Gonadotropin Receptors and Spermatogenesis in the Rat", Geilo, Norway (April 1978)
1978 5th Annual Workshop on the Testis, "Interactions Between LHRH, Sex Steroids and Inhibin in the Control of LH and FSH Secretion", Geilo, Norway (April 1978)
1983 5th International Catecholamine Symposium, "Catecholaminergic and Peptidergic Control of Pars Intermedia Cell Activity", Goteborg (June 1983)
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards